一个模式灵活的框架,用于阿尔茨海默病的诊断,遵循临床常规
IEEE journal of biomedical and health informatics
|October 1, 2024
概括
这项研究引入了一种灵活的框架,用于在不同临床阶段使用表格,MRI和PET数据来诊断阿尔茨海默病 (AD). 模式灵活的方法提高了痴呆症检测的诊断准确性.
科学领域:
- 神经学 神经学
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 阿尔茨海默病 (AD) 是最常见的痴呆症,在老年人中发病率很高.
- 目前的AD诊断方法通常集中在特定的临床阶段或数据类型.
- 需要一种全面的诊断方法,适用于所有AD诊断阶段.
研究的目的:
- 为阿尔茨海默病 (AD) 诊断开发一种模式灵活的分类框架.
- 有效地整合表格,MRI和PET成像数据,以提高诊断性能.
- 创建适用于临床AD诊断程序不同阶段的框架.
主要方法:
- 设计了一个三个分支的框架:表格 (查),MRI (不确定的查) 和PET (具有挑战性的病例).
- 一个图像表格式变压器块被开发用于多模式数据的自适应融合.
- 该框架在四个由6495名受试者组成的队列中得到了验证.
主要成果:
- 与现有方法相比,拟议的框架显示出优越的诊断性能.
- 该框架在所有AD诊断阶段都取得了有希望的结果.
- 通过变压器块实现了成像和非成像模式的有效融合.
结论:
- 这种模式灵活的框架显示了在AD诊断中临床应用的巨大潜力.
- 该框架为AD检测的各个阶段提供了一种多功能解决方案.
- 多模式数据的自适应融合提高了阿尔茨海默病诊断的准确性.
相关概念视频
01:26Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170